2-Trimethylsilythiazole

What dictates the lower explosive limit in aerobic TBAF-mediated desilylation?

Process safety assessments for 2-trimethylsilylthiazole consumption in oxygenated environments pivot on the Tetrahydrofuran vapour / air mixture envelope, not solely on the silane itself. When tetra-n-butylammonium fluoride trihydrate (TBAF·3H₂O) is employed as the desilylating agent in unstabilised THF at concentrations above 0.8 M, peroxide accumulation can shift the autoignition onset by as much as 18 °C below the standard 321 °C DTA-derived value. Production-scale reactors fitted with oxygen sensors and continuous nitrogen sparging loops at 4–6 L/min per cubic metre of headspace are mandated under IEC 60079-10-1:2020 zoning; batch records from a Zhejiang multipurpose API facility documented a flash fire incident when the sparge failed for 47 minutes while reheating a 2.2 kg load of 2-TMS-thiazole dissolved in unstabilised THF with 1.05 eq of TBAF stock. Stoichiometric precision is non-negotiable—excess fluoride ion beyond 1.2 eq accelerates protodesilylation but also catalyses THF ring-opening oligomerisation, generating low-molecular-weight peroxides detectable by ASTM E298-17 iodometric titration strips embedded in-line. The coupling partner, typically an N-methylpiperazine-tethered aryl iodide with an electron-withdrawing group at the para position, is introduced as a THF solution after the desilylation exotherm plateaus; addition before thermal quenching allows the unreacted TBAF to attack the iodoarene’s C–I bond, producing 3–8 % dehalogenated by-product that co-crystallises and necessitates a secondary hexane/EtOAc (9:1 v/v) slurry purification. Palladium catalyst loading is held at 0.25 mol% Pd₂(dba)₃ with 0.75 mol% XPhos, a ligand ratio validated by kinetic profiling to outcompete fluoride-induced ligand displacement for at least 4 turnover cycles; the active catalyst resting state shifts from L₂Pd(0) to [L₂Pd(Ar)(F)]⁻ when TBAF concentration temporarily spikes, retarding oxidative addition of the aryl iodide and demanding a slow reverse-addition protocol rather than direct syringe-pump delivery. The 2-arylthiazole product isolation leverages pH-controlled hydrolysis: quenching into 2.0 M aqueous NH₄Cl at 5 °C retains the trimethylsilanol by-product in the organic phase while the thiazole partitions cleanly (pKₐ of protonated thiazole ≈ 2.5). Residual silicon content in the dried product is below 15 ppm by ICP-OES when a final charcoal-filtration step is applied, qualifying batches for downstream GMP amidation under ICH Q3D Elemental Impurities Guideline.

Compliance documentation for export of this intermediate routinely specifies CAS 18236-59-9 as a non-isolated intermediate under REACH Title II, Article 2(9)(c) exemption, provided the material is consumed in a contiguous synthetic sequence without warehousing. A certificate of analysis enumerating peroxide value (≤0.5 meq/kg, ASTM E298), headspace oxygen (≤0.5 vol% after nitrogen inerting), and TMS-thiazole assay (≥97.0 % GC-FID area %, column DB-5, 30 m × 0.25 mm, temperature ramp 80 °C to 280 °C at 15 °C/min) accompanies each drum shipped under argon blanket. The end product from this specific process window—2-(4-fluorophenyl)thiazole—is registered as an intermediate for a p38 MAP kinase inhibitor programme; batch yields on 500 g scale average 82 % isolated, with palladium content in the API below the 10 μg/day permitted daily exposure limit.

How fluoride source identity modifies the transmetalation rate in Pd-catalysed cross-coupling

Using 2-trimethylsilylthiazole as a masked nucleophile in Hiyama-type couplings places the transmetalation event under tight fluoride control, yet the counter-cation and hydration state of the fluoride source determine whether the reaction follows a first-order dependence on [F⁻] or deviates into sigmoidal kinetics. TBAF·3H₂O (1.1 eq) in anhydrous DMF at 60 °C delivers pentacoordinate intermediate [TMS-F-TBA]⁺·thiazolide within 2 min as monitored by ReactIR Si–C band disappearance at 1252 cm⁻¹, and the thiazolide anion transfers to Pd(II) with a rate constant of 4.2 × 10⁻³ s⁻¹. Substituting CsF (2.5 eq) in the same solvent system, the absence of a solubilising tetraalkylammonium counter-ion retards desilylation to a half-life exceeding 45 min and yields a heterogeneous slurry where only 22 % conversion is attainable before catalyst deactivation—palladium black precipitation is visible within 90 min. A granulated potassium fluoride on alumina (KF/Al₂O₃, 40 wt% KF) protocol circumvents the moisture sensitivity of TBAF while providing sufficient surface area (220 m²/g BET) to strip the TMS group without generating free thiazolide in solution; this solid-phase desilylation confines the active organometallic species at the liquid–solid interface and suppresses homocoupling to <1 % when aryl bromides are used as electrophiles. A producer of capecitabine intermediate analogues adopted KF/Al₂O₃ granules packed in a flow cartridge reactor (10 mm ID × 100 mm, bed volume 7.85 mL) to continuously generate the thiazolide stream, achieving 94 % conversion at a residence time of 6.4 min and a back-pressure of 4.2 bar. The resultant effluent bypasses the aqueous fluoride removal step entirely, eliminating silica gel plugging during downstream filtration. For electrophile scope, 4-bromobenzotrifluoride couples with >90 % selectivity; 2-bromopyridine demands pre-complexation of Pd with a bidentate ferrocenyl ligand (dppf, 1.5 eq relative to Pd) to avoid undesired pyridyl-thiazole coordination swapping that decelerates reductive elimination. Compliance with ICH M7(R2) guidelines for mutagenic impurity risk assessment requires the sponsor to demonstrate that residual fluoride ion (<50 ppm in the final API) and 4,4′-bis(dimethylamino)biphenyl-derived XPhos ligand fragments are absent above the Threshold of Toxicological Concern. This is accomplished by UPLC-MS/MS with a LOQ of 0.5 ppm on the target drug substance.

The synthesis of 2-cyclopropylthiazole, a key fragment in a Phase II JAK inhibitor candidate, benefits from 2-TMS-thiazole because the direct lithiation of 2-bromothiazole with n-BuLi at -78 °C in THF results in 12–15 % ring-opening regardless of inverse quench conditions, while the TMS variant circumvents metal–halogen exchange entirely. Molecular sieves (3 Å, 20 wt% relative to silane) are added to the TBAF stock beforehand to scavenge adventitious water that would otherwise protonate the thiazolide and lower the effective nucleophile concentration; this increases the isolated yield from 74 % to 89 % on multikilogram scale. The operational simplicity of charging a premixed fluoride/silane stoichiometric blend into a Pd-precatalyst solution has allowed a CDMO in Hyderabad to execute the process in standard glass-lined reactors without requiring dedicated cryogenic units previously necessitated by organolithium alternatives.

Vapour pressure data for 2-trimethylsilylthiazole (bp 165–167 °C at 760 mmHg) and its Reid Vapour Pressure of <0.1 kPa at 37.8 °C classify it outside the scope of the Dangerous Goods Regulations for flammable liquids (UN Class 3), but the moist air sensitivity demands UN Product Code SGG1 segregation from water-reactive substances. A mandatory Stability in Sealed Containers test per UN Manual of Tests and Criteria Part II, Section 28.4.4 verifies no pressure buildup over 14 days at 54 °C when the container is initially purged to 0.5 bar positive argon pressure.

When 2-TMS-thiazole replaces 2-bromothiazole in Negishi coupling sequences

In building-block supply chains that feed constitutional isomers of the macrocyclic domain of epothilone analogues, the direct zinc insertion into 2-bromothiazole necessitates Rieke zinc (prepared from ZnCl₂, lithium naphthalenide, and rigorously dried THF at –50 °C) and tolerates no more than 50 ppm water. The organozinc reagent derived from 2-TMS-thiazole, by contrast, forms at 0 °C when the silane is treated with freshly titrated diethylzinc (1.0 eq) in hexane/THF (4:1); transmetalation is evidenced by ethylene gas evolution quantified by a mass flow meter integrated into the reactor exhaust. The resulting thiazol-2-ylzinc ethylate couples with methyl (2S)-2-(4-bromobenzamido)propanoate under Pd-PEPPSI-IPent (1.5 mol%) catalysis at 23 °C within 18 h, preserving the S-chirality with 99.2 % ee as confirmed by chiral SFC analysis. Residual silicon levels spike to 80–120 ppm in the crude if ethylene sparging is incomplete; a crystallisation from MTBE/n-heptane (1:3 v/v) at –10 °C reduces Si to <5 ppm, suitable for continuation into macrolactamisation. A process hazard analysis triggered by the exothermicity of ethylene generation (ΔT_adiabatic calculated at +64 K for a 1.5 M concentration) led to the installation of a rupture disc rated at 4 barg with a discharge pathway routed to a thermal oxidiser. The major advantage over the bromothiazole route is the elimination of toxic lithium residues and naphthalene carryover, streamlining the waste profile for a facility operating under ISO 14001:2015 certification. This transformation is performed on 70 kg scale per campaign, supplying the fragment for a Type II diabetes candidate under an investigational new drug application (IND 142,573).

Protodesilylation as a traceless activation strategy for 2-unsubstituted thiazole

Generating 2-lithiothiazole by direct deprotonation requires 2.2 eq of LiTMP at –78 °C in THF and suffers from competing ring-opening above –40 °C; the trimethylsilyl group in 2-TMS-thiazole functions as a latent hydrogen placeholder that can be cleaved under mildly acidic conditions after serving as an ortho-directing auxiliary. Treatment of a THF solution of the silane with methanolic HCl (1.25 M, 1.1 eq HCl relative to silane) at 0 °C for 30 min yields 2-unsubstituted thiazole in quantitative conversion, with the trimethylsilanol recovered by azeotropic distillation with hexane. This approach enables access to C4-functionalised thiazoles that are cumbersome to prepare via the unsubstituted parent: a commercially relevant example is the preparation of 4-methylthiazole-2-carboxylic acid, a precursor to the O-acetylserine sulfhydrylase inhibitor class. The sequence begins with α-metalation of the TMS-thiazole at the C4 position using sec-BuLi·TMEDA (1.05 eq) in Et₂O at –78 °C; quenching with methyl iodide and subsequent protodesilylation with citric acid (10 % w/w aqueous solution) furnishes 4-methylthiazole in an 82 % two-step yield. The method avoids generation of off-spec colour bodies (APHA <50) that plague the Hantzsch thiazole synthesis using chloroacetone and thiourea, which requires carbon treatment and results in 8–12 % material loss during decolourisation. Regulatory classification of this use pattern falls under a site-limited intermediate exemption as defined by TSCA 40 CFR 720.30(g), requiring the manufacturer to maintain a production record demonstrating 100 % consumption within the same month of manufacture and no distribution outside the designated site boundary. All transfers of 2-TMS-thiazole between storage and the activation vessel are conducted via closed-loop nitrogen-padded dip-tubes with camlock fittings, and the receiving vessel is pre-charged with the methanol/HCl quench solution to ensure immediate conversion upon contact, thereby minimising occupational exposure to the silane.

Flame ionisation detection (FID) on a DB-WAX column (30 m × 0.53 mm × 1.0 μm film) resolves hexamethyldisiloxane—a condensation by-product from two molecules of trimethylsilanol—as a single peak at retention time 3.42 min; its presence above 0.05 area% triggers an investigation line clearance protocol under 21 CFR Part 211.67, since hexamethyldisiloxane has a permitted daily exposure of 2.5 mg/day per ICH Q3C Guideline for Residual Solvents Class 3. The silanol condensation is promoted by trace alkali metal contamination from glass-lined reactors; a quarterly vessel passivation with 5 % nitric acid at 60 °C for 4 h eliminates the surface alkalinity that autocatalyses the condensation, maintaining disiloxane levels below the reporting threshold across 12 consecutive campaigns.

Reactivity cliff-edge at sub-stoichiometric Pd in aerobic microwave protocols

Scaling a microwave-assisted 2-arylthiazole synthesis from 2 mL vial reactions to a 500 mL continuous-flow microwave reactor uncovers a non-linear catalyst deactivation profile when the dissolved oxygen concentration in DMF exceeds 1.2 mg/L. At 0.05 mol% Pd loading, the yield collapses from 88 % to 31 % upon a DO₂ increase from 0.4 mg/L to 0.9 mg/L, a window that standard nitrogen sparging cannot reliably hold during the 15 min residence time at 140 °C. The mechanism involves Pd(0) oxidation to PdO nanoparticles that leach into the solvent as palladium acetate complexes, consuming the available fluoride activator (TBAF) in an irreversible ligand exchange. A tube-in-tube gas-permeable Teflon AF-2400 membrane module (0.5 m length, 1.0 mm O.D.) placed immediately upstream of the microwave cavity strips residual oxygen to <0.15 mg/L when the shell side is purged with argon at 50 mL/min, rescuing the catalyst turnover number to 1,700. This configuration is recommended in the context of ISO 21331:2020 (Continuous-flow chemistry — General requirements) and should be considered when the facility’s solvent drum is stored under ambient pressure rather than inert gas. Reaction calorimetry tests in the microwave cavity record a specific heat release of –180 kJ/mol exothermic, which, when combined with the microwave absorptivity of 2-TMS-thiazole (tan δ = 0.073 at 2.45 GHz), mandates a maximum forward power limit of 85 W and a feedback control loop sampling dielectric parameters every 0.5 s to avoid thermal overshoot beyond the 155 °C safety interlock. Operators must be certified to NFPA 70E standard for electrical safety because the coupling loop generates a high electromagnetic field intensity zone adjacent to the magnetron waveguide; only non-metallic wetted parts (PEEK, ceramic) are permitted in the reactor body.

The 2-(3-trifluoromethylphenyl)thiazole derived from this flow protocol is an intermediate in the synthesis of a selective 5-HT₁B receptor antagonist; its fluorine content (19.7 wt%) requires the final API to undergo quantitative fluorine-19 NMR according to USP <761> as a release test, with acceptance criteria of ±2.0 % of theoretical. The trifluoromethyl group also imposes strict control of the fluorination by-product hydrofluoric acid; a calcium gluconate safety shower is positioned within 10 metres of the reaction zone, and waste aqueous phase is neutralised with limestone chips to pH 7–8 prior to drain disposal under local environmental permit limits. All glassware is rinsed with 5 % aqueous ammonia prior to cleaning to sequester fluoride residues. Such operational particularities illustrate that the process window for 2-TMS-thiazole in high-productivity microwave synthesis is bounded by oxygen fugacity, electromagnetic field homogeneity, and a ligand replenishment strategy, not merely by stoichiometry.